ACRYSOF® SN6AT5 (REF SN6AT5.270)Recalls & reported problems
Alcon Laboratories, Inc. · AcrySof(R) IQ TORIC ASTIGMATISM IOL, SINGLE-PIECE ACRYLIC FOLDABLE LENS, UV WITH BLUE LIGHTFILTER, 13.0mm LENGTH, 6.0mm BICONVEX TORICASPHERIC OPTIC, 3.00 D CYLINDER. · Class 3 · Implant
All models of ACRYSOF (353)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380652251136), received between Oct 18, 2024 and Oct 18, 2024 — classified as 1 malfunction.
The most frequently reported specific device problem is “Optical Decentration” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Optical Decentration1
Patient problems
- Visual Impairment1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionOct 18, 2024Optical Decentration; Optical Decentration
AN OTHER HEALTH CARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE IN RIGHT EYE, 3 WEEKS POSTOPERATIVELY THE PATIENT REFRACTED AT -3.00/-0.5X1 AND REPORTED REFRACTIVE SURPRISE AS TARGET WAS FOR EMMETROPIA. THE PATIENT WAS COMPLICATED WITH PRE-OPERATIVE HISTORY OF MILD ALBINISM AND NYSTAGMUS. SURGEON HAS REVIEWED THE PATIENT POST-OPERATIVELY AND CONFIDENT THAT THERE WAS NO RETAINED VISCOELASTIC. HOWEVER, IOL WAS SITTING MORE ANTERIOR THAN EXPECTED. SURGEON FELT IT WAS A PATIENT FACTOR RATHER THAN ISSUE WITH THE IOL. CONSERVATIVE MANAGEMENT WAS PLANNED. THE SURGEON WAS MONITORING THE PATIENT HAD A MYOPIC REFRACTIVE ERROR BUT OTHERWISE THE EYE WAS QUIET, AND PATIENT WAS PROCEEDING WITH SURGERY ON THE FELLOW EYE IN THE COMING DAYS. THERE WAS NO SECONDARY INTERVENTION PLANNED AND THE SURGEON WILL PROVIDE AN UPDATE IF FURTHER INFORMATION COMES FORWARD. ADDITIONAL INFORMATION HAS BEEN REQUESTED.
Patient problems: Visual Impairment
MAUDE report 20481147 ↗
Other intraocular lens devices
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens146 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens145 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens144 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens139 reports
- TECNIS SIMPLICITY DIB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens1 recall81 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens129 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens127 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens126 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page